Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

345
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
345
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

124
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
124
Relative Risk01:12

Relative Risk

1.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.6K
Probability Laws01:49

Probability Laws

43.8K
Overview
43.8K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

209
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
209
Hazard Ratio01:12

Hazard Ratio

517
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
517

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral status associated with xerostomia and oral health-related quality of life: an older population-based cross-sectional study in China.

BMC geriatrics·2026
Same author

Polarization-controlled optical logic operations in multimode fibers.

Optics express·2026
Same author

A Bayesian phase I/II platform design with survival efficacy endpoint for dose optimization.

Statistical methods in medical research·2026
Same author

High-Quality Perovskite Films Enabled by Solution-Processed Vacuum Evaporation for Flexible PIN-Type X-Ray Detectors.

Molecules (Basel, Switzerland)·2026
Same author

Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model.

Pharmaceutical statistics·2026
Same author

Nanostructured Transparent CuWO<sub>4</sub> Films with Highly-Oriented Crystallinity Preferential to a (010) Plane as Efficient and Robust Photoanode for Visible-Light-Driven Water Oxidation.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Dec 29, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

Estimating individualized treatment rules with risk constraint.

Xinyang Huang1, Jin Xu1

  • 1Key Laboratory of Advanced Theory and Application in Statistics and Data Science - MOE, School of Statistics, East China Normal University, Shanghai, China.

Biometrics
|February 1, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for individualized treatment rules (ITRs) to maximize patient benefit while controlling adverse event risks. The approach handles multi-category treatments and uses advanced optimization techniques for reliable results.

Keywords:
DC programmingindividualized treatment rulemulti-category classificationoutcome weighted learningpersonalized medicinerisk constraint

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Dec 29, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Biostatistics
  • Clinical Decision Support
  • Machine Learning in Healthcare

Background:

  • Individualized treatment rules (ITRs) aim to optimize patient outcomes by tailoring treatments to specific characteristics.
  • However, managing the risks associated with adverse events is crucial and often challenging in treatment personalization.

Purpose of the Study:

  • To develop a novel method for estimating optimal individualized treatment rules (ITRs).
  • To ensure that the proposed ITRs maximize clinical benefit while maintaining overall risk at a controlled level.
  • To accommodate multi-category treatment settings.

Main Methods:

  • The method utilizes two shifted ramp losses to approximate 0-1 loss functions for both the objective and constraint.
  • The estimation problem is reformulated as a difference of convex functions (DC) programming problem.
  • A relaxed DC algorithm is employed to solve the resulting nonconvex constrained optimization problem.

Main Results:

  • The proposed method effectively estimates optimal individualized treatment rules (ITRs) in multi-category settings.
  • The approach successfully balances maximizing clinical benefit with controlling overall risk.
  • Simulations and a real data example confirm the method's finite sample performance.

Conclusions:

  • The developed method provides a robust framework for personalized medicine, optimizing treatment selection under risk constraints.
  • This approach advances the estimation of individualized treatment rules (ITRs) by addressing both efficacy and safety.
  • The technique is applicable to complex clinical scenarios involving multiple treatment options and risk considerations.